Connor, Clark & Lunn Investment Management Ltd. Homology Medicines, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$0.84 - $1.43 $68,034 - $115,821
-80,994 Reduced 87.46%
11,612 $13,000
Q2 2023

Aug 10, 2023
SELL
$0.83 - $1.12 $66,042 - $89,117
-79,569 Reduced 46.21%
92,606 $81,000
Q1 2023

May 09, 2023
SELL
$0.91 - $1.69 $22,568 - $41,913
-24,801 Reduced 12.59%
172,175 $177,000
Q4 2022

Feb 10, 2023
SELL
$1.09 - $2.04 $39,049 - $73,083
-35,825 Reduced 15.39%
196,976 $248,000
Q3 2022

Nov 10, 2022
BUY
$1.55 - $3.01 $8,686 - $16,868
5,604 Added 2.47%
232,801 $375,000
Q2 2022

Aug 05, 2022
BUY
$1.39 - $3.12 $43,483 - $97,602
31,283 Added 15.97%
227,197 $448,000
Q1 2022

May 12, 2022
SELL
$2.6 - $4.17 $19,890 - $31,900
-7,650 Reduced 3.76%
195,914 $596,000
Q4 2021

Feb 10, 2022
BUY
$3.64 - $7.78 $333,733 - $713,309
91,685 Added 81.95%
203,564 $741,000
Q3 2021

Nov 12, 2021
BUY
$6.01 - $8.71 $170,040 - $246,432
28,293 Added 33.85%
111,879 $880,000
Q2 2021

Aug 12, 2021
BUY
$6.02 - $9.64 $503,187 - $805,769
83,586 New
83,586 $608,000

Others Institutions Holding FIXX

# of Institutions
3
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email